Y10S 930/141
Interleukin
Y10S930/141 (Interleukin) appears on 115 US grants and 12 published applications in this corpus.
Search patents in Y10S- Granted patents
- 115
- Published applications
- 12
- Assignees
- 66
- Inventors
- 211
- Latest grant
- 3 Feb 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 9 | 0 |
| 1989 | 8 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 12 | 0 |
| 1995 | 2 | 0 |
| 1996 | 8 | 0 |
| 1997 | 12 | 0 |
| 1998 | 9 | 0 |
| 1999 | 12 | 0 |
| 2000 | 7 | 0 |
| 2001 | 6 | 1 |
| 2002 | 7 | 1 |
| 2003 | 0 | 3 |
| 2004 | 1 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 3 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods for treating myocardial infarction comprising administering an IL-6 inhibitor3 Feb 2015US 8,945,558 B2Chugai Seiyaku Kabushiki Kaisha
- Methods of using Fc-cytokine fusion proteins25 Oct 2011US 8,043,608 B2Merck Patent GmbH
- Multimarker panel based on PIGF for diabetes types 1 and 214 Jun 2011US 7,960,123 B2Roche Diagnostics Operations, Inc.
- Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens7 Jun 2011US 7,955,590 B2Merck Patent GmbH
- Conjugates targeted to the interleukin-2 receptor17 Feb 2004US 6,693,083 B2Watson Pharmaceuticals, Inc.
- Methods of using Fc-Cytokine fusion proteins18 Mar 2010US 2010/0068175 A1Merck Patent GmbH
- Agents for treating cardiopathy3 Sep 2009US 2009/0220500 A1Chugai Seiyaku Kabushiki Kaisha
- Use of interleukin-1514 Jun 2007US 2007/0134718 A1
- Multimarker panel based on PIGF for diabetes type 1 and 212 Jan 2006US 2006/0008829 A1Roche Diagnostics Operations, Inc.
- Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens24 Nov 2005US 2005/0261229 A1EMD Lexigen Research Center Corp.
Most cited
By later US patents
- Interleukin-2 muteins and polymer conjugation thereof444US 5,206,344 ACetus Oncology Corporation · 1993
- Human recombinant interleukin-2 muteins297US 4,518,584 ACetus Corporation · 1985
- Human recombinant cysteine depleted interferon-.beta. muteins253US 4,588,585 ACetus Corporation · 1986
- Chimeric ligand/immunoglobulin molecules and their uses239US 5,349,053 AProtein Design Labs, Inc. · 1994
- Cysteine added variants of interleukin-3 and chemical modifications thereof202US 5,166,322 AGenetics Institute, Inc. · 1992